The global Targeted RNA Sequencing market size is predicted to grow from US$ 3169 million in 2025 to US$ 11160 million in 2031; it is expected to grow at a CAGR of 23.3% from 2025 to 2031.
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.
In the report, we only collect information about the companies who can provide targeted RNA sequencing service.
Market competition is not intense. Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, etc. are the leaders of the industry, with about 52% market shares.
North America is the largest consumption place, with a consumption market share nearly 32%. Following North America, Europe is the second largest consumption place with the consumption market share of 28%.
The 鈥淭argeted RNA Sequencing Industry Forecast鈥� looks at past sales and reviews total world Targeted RNA Sequencing sales in 2024, providing a comprehensive analysis by region and market sector of projected Targeted RNA Sequencing sales for 2025 through 2031. With Targeted RNA Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted RNA Sequencing industry.
This Insight Report provides a comprehensive analysis of the global Targeted RNA Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Targeted RNA Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Targeted RNA Sequencing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted RNA Sequencing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted RNA Sequencing.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted RNA Sequencing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Exome Sequencing
Enrichment Sequencing
Amplicon Sequencing
Segmentation by Application:
Research Institutes
Hospitals & Clinics
Biotechnology Company
Diagnostic Lab
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher
Illumina
Roche Holdings
BGI
Eurofins
LabCorp
Berry Genomics
Macrogen
GENEWIZ
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Targeted RNA Sequencing Market Size (2020-2031)
2.1.2 Targeted RNA Sequencing Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Targeted RNA Sequencing by Country/Region (2020, 2024 & 2031)
2.2 Targeted RNA Sequencing Segment by Type
2.2.1 Exome Sequencing
2.2.2 Enrichment Sequencing
2.2.3 Amplicon Sequencing
2.3 Targeted RNA Sequencing Market Size by Type
2.3.1 Targeted RNA Sequencing Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Targeted RNA Sequencing Market Size Market Share by Type (2020-2025)
2.4 Targeted RNA Sequencing Segment by Application
2.4.1 Research Institutes
2.4.2 Hospitals & Clinics
2.4.3 Biotechnology Company
2.4.4 Diagnostic Lab
2.5 Targeted RNA Sequencing Market Size by Application
2.5.1 Targeted RNA Sequencing Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Targeted RNA Sequencing Market Size Market Share by Application (2020-2025)
3 Targeted RNA Sequencing Market Size by Player
3.1 Targeted RNA Sequencing Market Size Market Share by Player
3.1.1 Global Targeted RNA Sequencing Revenue by Player (2020-2025)
3.1.2 Global Targeted RNA Sequencing Revenue Market Share by Player (2020-2025)
3.2 Global Targeted RNA Sequencing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Targeted RNA Sequencing by Region
4.1 Targeted RNA Sequencing Market Size by Region (2020-2025)
4.2 Global Targeted RNA Sequencing Annual Revenue by Country/Region (2020-2025)
4.3 Americas Targeted RNA Sequencing Market Size Growth (2020-2025)
4.4 APAC Targeted RNA Sequencing Market Size Growth (2020-2025)
4.5 Europe Targeted RNA Sequencing Market Size Growth (2020-2025)
4.6 Middle East & Africa Targeted RNA Sequencing Market Size Growth (2020-2025)
5 Americas
5.1 Americas Targeted RNA Sequencing Market Size by Country (2020-2025)
5.2 Americas Targeted RNA Sequencing Market Size by Type (2020-2025)
5.3 Americas Targeted RNA Sequencing Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted RNA Sequencing Market Size by Region (2020-2025)
6.2 APAC Targeted RNA Sequencing Market Size by Type (2020-2025)
6.3 APAC Targeted RNA Sequencing Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Targeted RNA Sequencing Market Size by Country (2020-2025)
7.2 Europe Targeted RNA Sequencing Market Size by Type (2020-2025)
7.3 Europe Targeted RNA Sequencing Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Targeted RNA Sequencing by Region (2020-2025)
8.2 Middle East & Africa Targeted RNA Sequencing Market Size by Type (2020-2025)
8.3 Middle East & Africa Targeted RNA Sequencing Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Targeted RNA Sequencing Market Forecast
10.1 Global Targeted RNA Sequencing Forecast by Region (2026-2031)
10.1.1 Global Targeted RNA Sequencing Forecast by Region (2026-2031)
10.1.2 Americas Targeted RNA Sequencing Forecast
10.1.3 APAC Targeted RNA Sequencing Forecast
10.1.4 Europe Targeted RNA Sequencing Forecast
10.1.5 Middle East & Africa Targeted RNA Sequencing Forecast
10.2 Americas Targeted RNA Sequencing Forecast by Country (2026-2031)
10.2.1 United States Market Targeted RNA Sequencing Forecast
10.2.2 Canada Market Targeted RNA Sequencing Forecast
10.2.3 Mexico Market Targeted RNA Sequencing Forecast
10.2.4 Brazil Market Targeted RNA Sequencing Forecast
10.3 APAC Targeted RNA Sequencing Forecast by Region (2026-2031)
10.3.1 China Targeted RNA Sequencing Market Forecast
10.3.2 Japan Market Targeted RNA Sequencing Forecast
10.3.3 Korea Market Targeted RNA Sequencing Forecast
10.3.4 Southeast Asia Market Targeted RNA Sequencing Forecast
10.3.5 India Market Targeted RNA Sequencing Forecast
10.3.6 Australia Market Targeted RNA Sequencing Forecast
10.4 Europe Targeted RNA Sequencing Forecast by Country (2026-2031)
10.4.1 Germany Market Targeted RNA Sequencing Forecast
10.4.2 France Market Targeted RNA Sequencing Forecast
10.4.3 UK Market Targeted RNA Sequencing Forecast
10.4.4 Italy Market Targeted RNA Sequencing Forecast
10.4.5 Russia Market Targeted RNA Sequencing Forecast
10.5 Middle East & Africa Targeted RNA Sequencing Forecast by Region (2026-2031)
10.5.1 Egypt Market Targeted RNA Sequencing Forecast
10.5.2 South Africa Market Targeted RNA Sequencing Forecast
10.5.3 Israel Market Targeted RNA Sequencing Forecast
10.5.4 Turkey Market Targeted RNA Sequencing Forecast
10.6 Global Targeted RNA Sequencing Forecast by Type (2026-2031)
10.7 Global Targeted RNA Sequencing Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Targeted RNA Sequencing Forecast
11 Key Players Analysis
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Information
11.1.2 Thermo Fisher Targeted RNA Sequencing Product Offered
11.1.3 Thermo Fisher Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Thermo Fisher Main Business Overview
11.1.5 Thermo Fisher Latest Developments
11.2 Illumina
11.2.1 Illumina Company Information
11.2.2 Illumina Targeted RNA Sequencing Product Offered
11.2.3 Illumina Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Illumina Main Business Overview
11.2.5 Illumina Latest Developments
11.3 Roche Holdings
11.3.1 Roche Holdings Company Information
11.3.2 Roche Holdings Targeted RNA Sequencing Product Offered
11.3.3 Roche Holdings Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Roche Holdings Main Business Overview
11.3.5 Roche Holdings Latest Developments
11.4 BGI
11.4.1 BGI Company Information
11.4.2 BGI Targeted RNA Sequencing Product Offered
11.4.3 BGI Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 BGI Main Business Overview
11.4.5 BGI Latest Developments
11.5 Eurofins
11.5.1 Eurofins Company Information
11.5.2 Eurofins Targeted RNA Sequencing Product Offered
11.5.3 Eurofins Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Eurofins Main Business Overview
11.5.5 Eurofins Latest Developments
11.6 LabCorp
11.6.1 LabCorp Company Information
11.6.2 LabCorp Targeted RNA Sequencing Product Offered
11.6.3 LabCorp Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 LabCorp Main Business Overview
11.6.5 LabCorp Latest Developments
11.7 Berry Genomics
11.7.1 Berry Genomics Company Information
11.7.2 Berry Genomics Targeted RNA Sequencing Product Offered
11.7.3 Berry Genomics Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Berry Genomics Main Business Overview
11.7.5 Berry Genomics Latest Developments
11.8 Macrogen
11.8.1 Macrogen Company Information
11.8.2 Macrogen Targeted RNA Sequencing Product Offered
11.8.3 Macrogen Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Macrogen Main Business Overview
11.8.5 Macrogen Latest Developments
11.9 GENEWIZ
11.9.1 GENEWIZ Company Information
11.9.2 GENEWIZ Targeted RNA Sequencing Product Offered
11.9.3 GENEWIZ Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 GENEWIZ Main Business Overview
11.9.5 GENEWIZ Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
